logo

For the Inventor, By the Inventor

Hamburg, Germany

Evotec Ag


USPTO Granted Patents = 24

% Expired Patents = 37.5



Trademarks = 2

Forward Citations = 22

Loading Chart...
Loading Chart...

52 inventors (with patents filed for the assignee):

goldMedal John Kincaid (5 out of 19 patents)

silverMedal Donogh John Roger O'Mahony (4 out of 11 patents)

bronzeMedal Zhi-Liang Wei (4 out of 10 patents)

4.  Carl J Kaub (4 out of 11 patents)

5.  Zhan Wang (3 out of 21 patents)

6.  David James Hallett (3 out of 3 patents)

7.  Michael G Kelly (3 out of 72 patents)

8.  Stefan Jäger (3 out of 3 patents)

9.  Karsten Gall (3 out of 4 patents)

10.  Adam James Davenport (2 out of 12 patents)

11.  Matthew Duncton (2 out of 42 patents)

12.  Kaupo Palo (2 out of 11 patents)

13.  Peet Kask (2 out of 17 patents)

14.  Yeyu Cao (2 out of 7 patents)

15.  Sumithra Gowlugari (2 out of 6 patents)


24 patents:

1. 9759659 - Method for detecting the impacts of interfering effects on experimental data (2017-09-12),
2. 9133122 - Amide compounds, compositions and uses thereof (2015-09-15),
3. 8946439 - Amide compounds, compositions and uses thereof (2015-02-03),
4. 8912176 - Azetidines as histamine H3 receptor antagonists (2014-12-16),
5. 8859545 - Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases (2014-10-14),
6. 8691804 - Azetidines and cyclobutanes as histamine H3 receptor antagonists (2014-04-08),
7. 8653091 - Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof (2014-02-18),
8. 8623859 - Bradykinin B1 antagonists (2014-01-07),
9. 8580577 - Method for detecting an analyte in a sample (2013-11-12),
10. 8574861 - PPM1E proteins and nucleic acids as targets for neurodegenerative diseases (2013-11-05),
11. RE44555 - Method for analyzing chemical and/or biological samples by means of particle images (2013-10-21),
12. 8163901 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2012-04-24),
13. 8153651 - Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same (2012-04-10),
14. 8076345 - 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof (2011-12-13),
15. 7867707 - Method for detecting analytes in a sample (2011-01-11),
Evotec AG is a global leader in drug discovery and development, headquartered in Hamburg, Germany. The company specializes in providing integrated solutions to pharmaceutical and biotechnology industries, focusing on innovative research and development services. Evotec's expertise spans various therapeutic areas, including neuroscience, oncology, and metabolic diseases, leveraging advanced technologies and collaborative partnerships to accelerate the drug development process. Their commitment to scientific excellence positions them as a key player in the biopharmaceutical landscape.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Evotec Ag
24 Patents

#45 in Hamburg

#1,908 in Germany

#26,628 in the World

Hamburg, DE
Hamburg, Germany

Evotec Ag

Forward Citations = 22

52 inventors:

goldMedal John Kincaid (5 out of 19 patents)

silverMedal Donogh John Roger O'Mahony (4 out of 11 patents)

bronzeMedal Zhi-Liang Wei (4 out of 10 patents)

4.  Carl J Kaub (4 out of 11 patents)

5.  Zhan Wang (3 out of 21 patents)

Please report any incorrect information to [email protected]
Loading…